Diabetes

NEW YORK — A new study published in the Nov. 22 issue of Archives of Internal Medicine suggested there is a two-way relationship between depression and diabetes.

WASHINGTON — The number of Americans diagnosed with diabetes and the related costs of the disease could reach catastrophic proportions, according to new research by the UnitedHealth Group.

BANNOCKBURN, Ill. Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health, Omron announced.

Under the partnership, Omron is supporting the AHA’s campaign to educate healthcare providers on treatments for high blood pressure, also known as hypertension, with the goal of reaching 50,000 providers by 2013.

ALEXANDRIA, Va. Musician and reality TV star Bret Michaels recently shared his struggles with Type 1 diabetes and related health issues with the American Diabetes Association's consumer magazine, Diabetes Forecast.

WESTPORT, Conn. — A diabetes community network is offering tips to diabetics that are traveling this holiday season.

DLife emphasized that since diabetes doesn't take a holiday, managing the condition shouldn't either. On its website, DLife.com, the company is offering such tips to diabetics as:

NEW YORK — Adding pharmacists to a primary care team could help diabetics better manage associated risks, according to a new study conducted by researchers from the University of Alberta.

Among 153 hypertensive Type 2 diabetes patients studied, 82 who had advice from a pharmacist were more likely to reach blood pressure treatment targets recommended by the Canadian Diabetes Association.

CHICAGO — A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the risk of cardiovascular disease compared with other diabetes treatments, the two companies said Wednesday.

According to a study presented at the American Heart Association’s scientific sessions in Chicago, use of Byetta (exenatide) was associated with a lower incidence of cardiovascular disease than insulin and several other drug classes.

NEW YORK and SAN DIEGO — A leading charitable funder of and advocate for Type 1 diabetes research and a drug maker have entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of an analog of the human hormone leptin in patients with Type 1 diabetes.